Heterotopic ossification in total hip arthroplasty: The significance for clinical outcome

Acta Orthopaedica Belgica

Volumn 66, Issue 2, 2000, Pages 174-180

  Eggli, S ^a,b   Rodriguez, J ^c   Ganz, R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Maurice E Müller Foundation   (Switzerland)

^c LENOX HILL HOSPITAL   (United States)

Author keywords

Functional results; Heterotopic ossification; Hip; Osteoarthritis; Prosthesis

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HETEROTOPIC OSSIFICATION; HUMAN; JOINT MOBILITY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATIENT SATISFACTION; TOTAL HIP PROSTHESIS; WALKING;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; HIP JOINT; HUMANS; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; PATIENT SATISFACTION; PROGNOSIS; PROSPECTIVE STUDIES; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME;

EID: 0034065238     PISSN: 00016462     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Ahrengart L. Periarticular heterotopic ossification after total hip arthroplasty. Risk factors and consequences. Clin. Orthop., 1991, 263, 49-S8.
2. Ahrengart L., Lindgren U Functional significance of heterotopic bone formation after total hip arthroplasty. J. Arthroplasty, 1989, 4, 125-131.
3. Ahrengart L., Lindgren U. Heterotopic bone after hip arthroplasty. Defining the patient at risk. Clin. Orthop., 1993, 293, 153-159.
4. Amstutz H. C., Fowble V. A., Schmalzried T. P., Dorey F. J. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty. J. Arthroplasty, 1997, 12, 126-132.
5. Ayers D. C., Pellegrini V., Jr., Evarts C. M. Prevention of heterotopic ossification in high-risk patients by radiation therapy. Clin. Orthop., 1991, 263, 87-93.
6. Brooker A. F., Bowerman J. W., Robinson R. A., Riley L. H. Ectopic ossification following total hip replacement. J. Bone Joint Surg., 1973, 55-A, 1629-1632.
7. Burssens A., Thiery J., Kohl P., Molderez A., Haazen L. Prevention of heterotopic ossification with tenoxicam following total hip arthroplasty : A double-blind, placebo-controlled dose-finding study. Acta Orthop. Belg., 1995, 61, 205-211.
8. Caron J. C. Para-articular ossification in total hip replacement. Gschwend N., DeBrunner H. V., (eds. ), 1976, Total Hip Prothesis, Hans Huber Verlag Bern, 171-185.
9. Cella J. P., Salvati E. A., Sculco T. P. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects. J. Arthroplasty, 1988, 3, 229-234.
10. Charnley J. The longterm results of low-friction arthroplasty of the hip performed as a primary intervention. J. Bone Joint Surg., 1972, 54-B, 61-76.
11. De Flitch C. J., Stryker J. A. Postoperative hip irradiation in prevention of heterotopic ossification : Causes of treatment failure. Radiology, 1993, 188, 265-270.
12. DeeLee J., Ferrari A., Charnley J. Ectopic bone formation following low friction hip arthroplasty of the hip. Clin. Orthop., 1976, 121, 53-59.
13. Dorn U., Grethen C., Effenberger H., Berka H., Ramsauer T., Drekonja T. Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment. Acta Orthop. Scand., 1998, 69, 107-110.
14. Duck H. J., Mylod A., Jr. Heterotopic bone in hip arthroplasties. Cemented versus noncemented. Clin. Orthop., 1992, 282, 145-153.
15. Fingeroth R. J., Ahmed A. Q. Single dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty. Clin. Orthop., 1995, 317, 131-140.
16. Freiberg A. A., Cantor R., Freiberg R. A. The use of aspirin to prevent heterotopic ossification after total hip arthroplasty. A preliminary report. Clin. Orthop., 1991, 267, 93-96.
17. Gebuhr P., Wilbek H., Soelberg M. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty. Clin. Orthop., 1995, 314, 166-169.
18. Goel A., Sharp D. J. Heterotopic bone formation after hip replacement. The influence of the type of osteoarthritis. J. Bone Joint Surg., 1991, 73-B, 255-257.
19. Goldmann A. R., Seegenschmiedt M., Andreas P., Hohmann D., Sauer R., Beck H. Radiation therapy in the prevention of periarticular, heterotopic ossification following implantation of a total hip endoprosthesis. Z. Orthop. Ihre Grenzgeb., 1993, 131, 151155.
20. Han C. D., Choi C. H., Sun C. O. Prevention of heterotopic bone formation after total hip arthroplasty using 600 rad in single dose in high risk patient. Yonsei Med. J., 1997, 38, 96-100.
21. Healy W. L., Lo T. C., Covall D. J., Pfeifer B. A., Wasilewski S. A. Single-dose radiation therapy for prevention of heterotopic ossification after total hip arthroplasty. J. Arthroplasty, 1990, 5, 369-375.
22. Heyd R., Schopohl B., Kirchner J., Bottcher H. D. Preoperative radiotherapy for prevention of heterotopic ossifications after hip endoprothesis. Aktuelle Radiol., 1997, 7, 270-273.
23. Heyd R., Schopohl B., Kirchner J., Bottcher H. D. Preoperative radiotherapy for prevention of heterotopic ossifications after hip endoprosthesis. Aktuelle Radiol., 1997, 7, 270-273.
24. Hierton C., Blomgren G., Lindgren U. Factors associated with heterotopic bone formation in cemented total hip prostheses. Acta Orthop. Scand., 1983, 54, 698-702.
25. Hochheim B., Wunsche F. Indomethacin in the prevention of para-articular ossification following total hip endoprosthesis. Beitr. Orthop. Traumatol., 1990, 37, 330-334.
26. Hofmann S., Trnka HJ., Metzenroth H., Frank E., Ritsch P., Salzer M. General short term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty. Orthopedics, 1999, 22, 207-211.
27. Hoikka V., Lindholm T. S., Eskola A. Flurbiprofen inhibits heterotopic bone formation in total hip arthroplasty. Arch. Orthop. Trauma Surg., 1990, 109, 224-226.
28. Horwitz B. R., Rockowitz N. L., Goll S. R., Booth R., Jr., Balderston R. A., Rothman R. H. et al. A prospective randomized comparison of two surgical approaches to total hip arthroplasty. Clin. Orthop., 1993, 291, 154-163.
29. Kennedy W. F., Gruen T. A., Chessin H., Gasparini G., Thompson W. Radiation therapy to prevent heterotopic ossification after cementless total hip arthroplasty. Clin. Orthop., 1991, 262, 185-191.
30. Kjaersgaard-Andersen P. Heterotopic ossification with total hip endoprostheses in various models of thrombosis prophylaxis. J. Arthroplasty, 1989, 4, 97-98.
31. Kjaersgaard-Andersen P., Hougaard K., Linde F., Christiansen S. E., Jensen J. Heterotopic bone formation after total hip arthroplasty in patients with primary or secondary coxarthrosis. Orthopedics. 1990, 13, 1211-1217.
32. Kjaersgaard-Andersen P., Nafei A., Teichert G., Kristensen O., Schmidt S. A., Keller J. et al. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties. Acta Orthop. Scand., 1993, 64, 639-642.
33. Kjaersgaard-Andersen P., Steinke M. S., Hougaard K., Sojbjerg J. O., Jensen J. Heterotopic bone formation following hip arthroplasty. A retrospective study of 65 bilateral cases. Acta Orthop. Scand., 1991, 62, 223-225.
34. Kromann-Andersen C., Sorensen T. S., Hougaard K., Zdravkovic D., Frigaard E. Ectopic bone formation following Chamley hip arthroplasty. Acta Orthop. Scand., 1980, 51, 633-638.
35. Lazansky M. G. Complication revisited : The debit side of total hip replacement. Clin. Orthop., 1973, 95, 96-103.
36. Maloney W. J., Jasty M., Willett C., Mulroy R., Jr., Harris W. H. Prophylaxis for heterotopic bone formation after total hip arthroplasty using low-dose radiation in high risk patients. Clin. Orthop., 1992, 280, 230-234.
37. McMahon J. S., Waddell J. P., Morton J. Effect of short-course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty. J. Arthroplasty, 1991, 6, 259-264.
38. Metzenroth H., Publig W., Knahr K., Zandl C., Kuchner G., Carda C. Prevention of ossification after total hip endoprosthesis with indomethacin and its effect on gastric mucosa. Z. Orthop. Ihre Grenzgeb., 1991, 129, 178-182.
39. Morrey B. F., Adams R. A., Cabanela M. E. Comparison of heterotopic bone after anterolateral, transtrochanteric, and posterior approaches for total hip arthroplasty. Clin. Orthop., 1984, 188, 160-167.
40. Müller M. E., Sledge C., Poss R., Schatzker J., Engel C., Paterson D. Report of the SICOT Presidential Commission on documentation and evaluation. Int. Orthop., 1990, 14, 221-227.
41. Nilsson O. S., Persson P. E. Heterotopic bone formation after joint replacement. Curr. Opin. Rheumatol., 1999, 11, 127-131.
42. Nollen J. G., van Douveren F. Q. Ectopic ossification in hip arthroplasty. A retrospective study of predisposing factors in 637 cases. Acta Orthop. Scand., 1993, 64, 185-187.
43. Pai V. S. Heterotopic ossification in total hip arthroplasty. The influence of the approach. J. Arthroplasty, 1994, 9, 199-202.
44. Parker H. C., Wiesman H. J., Edward F. C., Thomas W. H., Sledge C. B. Comparisons of immediate and late results of total hip replacement with and without trochanteric osteotomy. J. Bone Joint Surg., 1974, 56-A, 1537.
45. Pedersen N. W., Kristensen S. S., Schmidt S. A., Pedersen P., Kjaersgaard-Andersen P. Factors associated with heterotopic bone formation following total hip replacement. Arch. Orthop. Trauma Surg., 1989, 108, 92-95.
46. Persson P. E., Sodemann B., Nilsson O. S, Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized doubleblind prospective study of treatment time. Acta Orthop. Scand., 1998, 69, 111-115.
47. Riegler H. F., Harris C. M. Heterotopic bone formation after total hip arthroplasty. Clin. Orthop., 1976, 117, 209.
48. Ritter M. A., Vaughan R. B. Ectopic ossification after total hip arthroplasty. J. Bone Joint Surg., 1977, 59-A, 345-351.
49. Seegenschmiedt M. H., Goldmann A. R., Martus P., Wolfel R., Hohmann D., Sauer R. Prophylactic radiation therapy for prevention of heterotopic ossification after hip arthroplasty : Results in 141 high-risk hips. Radiology, 1993, 188, 257-264.
50. Shaffer B. A critical review. Heterotopic ossification in total hip replacement. Bull. Hosp. Jt. Dis., 1989, 49, 55-74.
51. Soballe K., Christensen F., Kristensen S. S. Ectopic bone formation after total hip arthroplasty. Clin. Orthop., 1988, 228, 57-62.
52. Sodemann B., Persson P. E., Nilsson O. Etiology and treatment of periarticular heterotopic ossification after total hip replacement. Rev. Chir. Orthop., 1988, 74, Suppl. II, 329-330.
53. Sodemann B., Persson P. E., Nilsson O. S. Nonsteroid anti-inflammatory drugs prevent the recurrence of heterotopic ossification after excision. Arch. Orthop. Trauma Surg., 1990, 109, 53-56.
54. Sudanese A., Tabarroni M., Busanelli L., Testoni M., Toni A., Spagnolli M. F. et al. The use of cobalt therapy to prevent heterotopic ossification after total hip arthroplasty. Chir. Organi Mov., 1996, 81, 89-106.
55. Taylor A. R., Kamder B. A., GP A. Ectopic ossification following total hip replacement. J. Bone Joint Surg., 1976, 58-B, 134-.
56. Thomas B. J. Heterotopic bone formation after total hip arthroplasty. Orthop. Clin. North Am., 1992, 23, 347-358.
57. Vastel L., Kerboull L., Anract P., Kerboull M. Heterotopic ossification after total hip arthroplasty : Risk factors and prevention. Rev. Rheum. (Engl Ed), 1998, 65, 238-244.
58. Warren S. B. Heterotopic ossification after total hip replacement. Orthop. Rev., 1990, 19, 603-611.
59. Wurnig C., Eyb R., Auersperg V. Indomethacin for prevention of ectopic ossification in cementless hip arthroplasties. A prospective 1-year study of 100 cases. Acta Orthop. Scand., 1992, 63, 628-630.